About GATEWAY BIOTECHNOLOGY, INC
Gateway Biotechnology Inc. is a biotechnology company focused on developing first-in-class drug therapies for hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded in 2011 based on research initiated in 2006 at Washington University in St. Louis.
Development of first-in-class drug therapies for hearing disordersResearch and development of gene therapeutic approaches for tinnitusPreclinical and clinical development of therapies for noise-induced and age-related hearing loss
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PH II, PROPOSAL NO. H2S-0048, TITLED: "GW-TT2, A NEW DRUG P | Department of Defense | $1.3M |
Teaming History
Prime contractors GATEWAY BIOTECHNOLOGY, INC has worked under:
- Washington University, The — 1 subcontract(s)
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GATEWAY BIOTECHNOLOGY, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.